Skip to main content

Table 2 HIV integration sites in latently infected cell lines

From: HIV integration sites in latently infected cell lines: evidence of ongoing replication

Cell line Replication competent virus Chromosomea Positionb Genec Gene orientationd HIV orientatione Percentage of eventsf
U1 Yes 2 48,177,527 AC079807.4 + ≈38%
   X 38,811,467    ≈55%
   19 34,452,847 UBA2 + + ≈3%
ACH-2 Yes 7 33,019,791 NT5C3A ≈37%
   9 128,111,651 SLC25A25-AS ≈13%
   2 26,386,668 EPT1 + + ≈2%
   17 81,558,479 NPLOC4 + ≈1%
J1.1 Yes 11 685,243 DEAF1 ≈41%
   12 54,257,973 CBX5 ≈38%
J-Lat 8.4 No 1 7,946,384 FUBP1 100%
J-Lat 9.2 No 19 4,381,104 PPP5C + + 100%
J-Lat 10.6 No 9 136,468,579 SEC16A + 100%
J-Lat 15.4 No 19 34,441,293 UBA2 + + 100%
J-Lat tat-GFP 8.2 No 10 39,936,068    + 100%
J-Lat tat-GFP A1 No X 34,073,326    100%
J-Lat tat-GFP H2 No 2 171,821,429 SLC25A12 + 100%
J-Lat tat-GFP A72 No X 45,038,538 KDM6A + 100%
  1. aThe particular chromosome where the HIV integration site is located
  2. bThe first human genome nucleotide following 3′-end LTR
  3. cThe gene where HIV is integrated
  4. dTranscription direction of the gene
  5. eTranscription direction of HIV
  6. fPercentage of events where the particular HIV integration site was detected in all passages